Sector revisions Highnoon Laboratories Limited

Stocks

End-of-day quote Pakistan S.E. 2026-09-30			5-day change	1st Jan Change
933.00 ^PKR	-1.08%		-2.73%	-8.75%

08-27	Highnoon Laboratories Limited Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026	CI
05-18	Highnoon Laboratories Appoints Dr. Shahzad Khan as Managing Director of Highnoon Life Sciences	CI

Sector:

Location:

X axis:

Main competitors

Add to a list 0 selected To use this feature you must be a member Log in Sign up	4m. EPS revision	1y. EPS revision	Visibility	Nbr of analysts
HIGHNOON LABORATORIES LIMITED	-	-	-	1
ELI LILLY AND COMPANY				29
JOHNSON & JOHNSON				22
ABBVIE INC.				28
MERCK & CO., INC.				25
ROCHE HOLDING AG				19
NOVARTIS AG				22
ASTRAZENECA PLC				23
AMGEN INC.				29
GILEAD SCIENCES, INC.				26
NOVO NORDISK A/S				23
PFIZER INC.				26
VERTEX PHARMACEUTICALS INCORPORATED				28
BRISTOL-MYERS SQUIBB COMPANY				24
MCKESSON CORPORATION				14
GSK PLC				21
SANOFI				24
MODERNA, INC.				18
REGENERON PHARMACEUTICALS, INC.				26
MERCK KGAA				14
Average				22
Weighted average by Cap.				25